VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2020 | Cytogenetic risk & the impact of daratumumab in myeloma

Luciano Costa, MD, PhD, of the UAB School of Medicine, Birmingham, AL, highlights results of a meta-analysis determining the impact of daratumumab in the treatment of multiple myeloma according to cytogenetic risk. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter